Valuence Merger Corp. I (VMCAF)

Market Cap	91.39M
Revenue (ttm)	n/a
Net Income (ttm)	1.84M
Shares Out	7.37M
EPS (ttm)	0.23
PE Ratio	54.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	12.40
Previous Close	12.40
Day's Range	12.40 - 12.40
52-Week Range	11.45 - 12.40
Beta	0.01
RSI	98.20
Earnings Date	Aug 14, 2025

About Ligand Pharmaceuticals

Valuence Merger Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities that is developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology in Asia. The company was incorporated in 2021 and is based in Orinda, California.

• Industry: Shell Companies
• Sector: Financials
• Founded: 2021
• Country: Cayman Islands
• Stock Exchange: OTCMKTS
• Ticker Symbol: VMCAF